Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Abortion’s new battleground: Mifepristone’s effect on women’s mental health

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

Los Angeles Times

Abortion drug remains approved, with restrictions, appeals court rules

Mifepristone will remain on the market, but approved only for use up to seven weeks of pregnancy, versus 10 weeks, and it cannot be prescribed by telehealth or mailed, which were already illegal in Texas.

The Texas Tribune

U.S. appeals court preserves partial access to abortion pill, but with tighter rules

The Biden administration had asked the higher court to stay a decision from a Texas judge while the appeal plays out.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Appeals court keeps abortion drug on the market, with some limits - Roll Call

A federal appeals court allowed the nation’s most-used medication abortion drug to remain on the market after Saturday.

Roll Call

US abortion pill providers see surge in interest after judge targets mifepristone

People are seeking the advance provision of medication before Friday’s deadline, when the drug may become unavailable

The Guardian - US

Texas abortion pill ruling partly blocked by appeals court – but barriers to access upheld

An appeals court ruling prevents an outright ban on mifepristone, but the conservative panel has effectively made the drug harder for millions of Americans to obtain

The Independent UK

Editorial: Judge had a basis for his attack on FDA, but not regarding mifepristone

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

St. Louis Post-Dispatch

Read news from The Economist, FT, and more,
with one subscription

Robin Abcarian: Hang on to the pill and your IUD. After abortion, birth control is the next fight

Mark my words: Contraception is the next front in the war on women. And we can't say we haven't been warned.

Los Angeles Times

Federal appeals court preserves access to abortion drug but with tighter rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail.

WEKU

Court preserves access to abortion drug, tightens rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail

The Independent UK

"I never took Ozempic with weight loss in mind - but it's totally changed my life."

Three women share their honest experiences taking the controversial diabetes drug.

Marie Claire

Federal appeals court partially blocks Texas abortion pill ruling

The ruling means mifepristone is still available in the U.S., but with several strict limitations.

Axios

Feds launch criminal investigation into ‘AGGA’ dental device and its inventor

Federal prosecutors have launched a criminal investigation into the Anterior Growth Guidance Appliance, or “AGGA” dental device, following a recent KFF Health News-CBS News investigation, according to a motion filed in federal court.

Tribune News Service

Juul to pay Illinois $67.6 million as part of multi-state settlement in vaping lawsuit

The e-cigarette manufacturer will pay $462 million in all to settle the lawsuit, which alleges the company marketed to minors and misled consumers about health risks.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Members of Congress weigh in on court fight over abortion drug

WASHINGTON — A Louisiana-based federal appeals court could decide as soon as Wednesday the availability of the nation’s most used medication abortion drug, as members of Congress from both parties weighed in on a lower court ruling that would stop the manufacture and distribution of the drug this Saturday.

The Independent UK

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

Axios

What to know about the Comstock Act as abortion pill fight escalates

Anti-abortion groups have revived the centuries-old law.

Al Jazeera

White House vows to fight for abortion pills, patient privacy

Moves follow Texas ruling suspending federal approval for abortion pills, state efforts to restrict travel for abortion.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Kimmel on Covid after the US national emergency: ‘It’s kinda like a crazy ex’

Late-night hosts discuss Biden ending the Covid national emergency, a federal judge’s abortion pill ruling and Trump’s spin on his arraignment

Roll Call

Members of Congress weigh in on court fight over abortion drug - Roll Call

Members of Congress weighed in on a lower court ruling that would stop the manufacture and distribution of an abortion drug.

The Guardian - US

To protect abortion access, the FDA should decline to enforce a mifepristone ban

Try as it might, the Food and Drug Administration cannot escape the abortion debate. The agency must be bolder

The Guardian - UK

First Thing: Zelenskiy urges world leaders to act over beheading videos

Ukrainian president calls for action after videos circulated online appear to show soldiers beheaded by Russian forces. Plus, Nasa prepares for life on Mars

Tribune News Service

Editorial: Dems float idea of ignoring the federal judiciary

Imagine the reaction if a federal court a few years back had ruled against a controversial White House executive order, and Trump administration officials responded by ignoring the decision. Apoplectic progressives would have taken to the streets to protest the president as an “existential threat to democracy” — and rightfully…

Tribune News Service

Lisa Jarvis: Abortion pill ruling threatens pharmaceutical innovation

A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise.

Tribune News Service

Editorial: Missouri and Kansas AGs want to block abortion pill — for democracy, says Kris Kobach

If in the near future the U.S. Supreme Court decides to ban the abortion pill, you’ll have Andrew Bailey and Kris Kobach to blame.

1 … 138 139 140 141

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

336 stories

APA

250 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.